DAPKCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。DAPK遺伝子サイレンサーは、DAPK CRISPR/Cas9ノックアウトプラスミドとDAPKDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のDAPKCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
DAPK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
DAPK CRISPR/Cas9 KOプラスミド (h) | sc-402702 | h | Gene Knockout | GFP | 0 | ||
DAPK HDRプラスミド (h) | sc-402702-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
DAPK Double Nickaseプラスミド (h) | sc-402702-NIC | h | Gene Knockout | Puromycin | 0 | ||
DAPK Double Nickaseプラスミド (h2) | sc-402702-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
DAPK CRISPR/Cas9 KOプラスミド (m) | sc-427475 | m | Gene Knockout | GFP | 0 | ||
DAPK HDRプラスミド (m) | sc-427475-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
DAPK Double Nickaseプラスミド (m) | sc-427475-NIC | m | Gene Knockout | Puromycin | 0 | ||
DAPK Double Nickaseプラスミド (m2) | sc-427475-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
DAPK2 CRISPR/Cas9 KOプラスミド (h) | sc-404468 | h | Gene Knockout | GFP | 0 | ||
DAPK2 HDRプラスミド (h) | sc-404468-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
DAPK2 Double Nickaseプラスミド (h) | sc-404468-NIC | h | Gene Knockout | Puromycin | 0 | ||
DAPK2 Double Nickaseプラスミド (h2) | sc-404468-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
DAPK2 CRISPR/Cas9 KOプラスミド (m) | sc-419944 | m | Gene Knockout | GFP | 0 | ||
DAPK2 HDRプラスミド (m) | sc-419944-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
DAPK2 Double Nickaseプラスミド (m) | sc-419944-NIC | m | Gene Knockout | Puromycin | 0 | ||
DAPK2 Double Nickaseプラスミド (m2) | sc-419944-NIC-2 | m | Gene Knockout | Puromycin | 0 |
DAPK CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
DAPK CRISPR Activationプラスミド (h) | sc-402702-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK CRISPR Activationプラスミド (h2) | sc-402702-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK Lentiviral Activation Particles (h) | sc-402702-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK Lentiviral Activation Particles (h2) | sc-402702-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK CRISPR Activationプラスミド (m) | sc-427475-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK CRISPR Activationプラスミド (m2) | sc-427475-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK Lentiviral Activation Particles (m) | sc-427475-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK Lentiviral Activation Particles (m2) | sc-427475-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 CRISPR Activationプラスミド (h) | sc-404468-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 CRISPR Activationプラスミド (h2) | sc-404468-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 Lentiviral Activation Particles (h) | sc-404468-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 Lentiviral Activation Particles (h2) | sc-404468-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 CRISPR Activationプラスミド (m) | sc-419944-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 CRISPR Activationプラスミド (m2) | sc-419944-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 Lentiviral Activation Particles (m) | sc-419944-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAPK2 Lentiviral Activation Particles (m2) | sc-419944-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |